These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34819628)

  • 1. Diving into the dark kinome: lessons learned from LMTK3.
    Vella V; Giamas G; Ditsiou A
    Cancer Gene Ther; 2022 Aug; 29(8-9):1077-1079. PubMed ID: 34819628
    [No Abstract]   [Full Text] [Related]  

  • 2. LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma.
    Klug LR; Bannon AE; Javidi-Sharifi N; Town A; Fleming WH; VanSlyke JK; Musil LS; Fletcher JA; Tyner JW; Heinrich MC
    Oncogene; 2019 Feb; 38(8):1200-1210. PubMed ID: 30242244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
    Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
    Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMTK3 knockdown retards cell growth and invasion and promotes apoptosis in thyroid cancer.
    Lu L; Yuan X; Zhang Q; Zhang H; Shen B
    Mol Med Rep; 2017 Apr; 15(4):2015-2022. PubMed ID: 28260052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.
    Jiang T; Lu X; Yang F; Wang M; Yang H; Xing N
    FEBS Open Bio; 2020 Oct; 10(10):2107-2121. PubMed ID: 32865871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMTK3 deficiency causes pronounced locomotor hyperactivity and impairs endocytic trafficking.
    Inoue T; Hoshina N; Nakazawa T; Kiyama Y; Kobayashi S; Abe T; Yamamoto T; Manabe T; Yamamoto T
    J Neurosci; 2014 Apr; 34(17):5927-37. PubMed ID: 24760852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer.
    Xu Y; Zhang H; Nguyen VT; Angelopoulos N; Nunes J; Reid A; Buluwela L; Magnani L; Stebbing J; Giamas G
    Cell Rep; 2015 Aug; 12(5):837-49. PubMed ID: 26212333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of cyclic guanidine-linked sulfonamides as inhibitors of LMTK3 kinase.
    Ortiz MA; Michaels H; Molina B; Toenjes S; Davis J; Marconi GD; Hecht D; Gustafson JL; Piedrafita FJ; Nefzi A
    Bioorg Med Chem Lett; 2020 May; 30(9):127108. PubMed ID: 32192797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
    Cairns J; Ingle JN; Kalari KR; Shepherd LE; Kubo M; Goetz MP; Weinshilboum RM; Wang L
    Breast Cancer Res; 2019 Apr; 21(1):47. PubMed ID: 30944027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum LMTK3 as a novel biomarker in non-small cell lung cancer.
    Xu Z; Qi X; Zhang X; Yu L
    Tumour Biol; 2014 May; 35(5):5007-11. PubMed ID: 24510346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural modeling and molecular dynamics studies on the human LMTK3 domain and the mechanism of ATP binding.
    Anbarasu K; Jayanthi S
    Mol Biosyst; 2014 May; 10(5):1139-45. PubMed ID: 24619340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and optimization of novel human LMTK3 inhibitors against breast cancer - a computational approach.
    Anbarasu K; Jayanthi S
    J Recept Signal Transduct Res; 2017 Feb; 37(1):51-59. PubMed ID: 27056562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.
    Xu Y; Zhang H; Lit LC; Grothey A; Athanasiadou M; Kiritsi M; Lombardo Y; Frampton AE; Green AR; Ellis IO; Ali S; Lenz HJ; Thanou M; Stebbing J; Giamas G
    Sci Signal; 2014 Jun; 7(330):ra58. PubMed ID: 24939894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMTK3 confers chemo-resistance in breast cancer.
    Stebbing J; Shah K; Lit LC; Gagliano T; Ditsiou A; Wang T; Wendler F; Simon T; Szabó KS; O'Hanlon T; Dean M; Roslani AC; Cheah SH; Lee SC; Giamas G
    Oncogene; 2018 Jun; 37(23):3113-3130. PubMed ID: 29540829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Virtual Screening of High-Affinity ATP-Competitive Inhibitors Against Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: A Novel Therapeutic Target for Breast Cancer.
    Sarma H; Mattaparthi VSK
    Interdiscip Sci; 2019 Sep; 11(3):527-541. PubMed ID: 30066129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
    Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
    Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
    Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
    Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMTK3 is implicated in endocrine resistance via multiple signaling pathways.
    Stebbing J; Filipovic A; Lit LC; Blighe K; Grothey A; Xu Y; Miki Y; Chow LW; Coombes RC; Sasano H; Shaw JA; Giamas G
    Oncogene; 2013 Jul; 32(28):3371-80. PubMed ID: 22869149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lmtk3-KO Mice Display a Range of Behavioral Abnormalities and Have an Impairment in GluA1 Trafficking.
    Montrose K; Kobayashi S; Manabe T; Yamamoto T
    Neuroscience; 2019 Aug; 414():154-167. PubMed ID: 31310731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway.
    Wang C; Yang M; Gu X; Gu Y
    Bioengineered; 2021 Dec; 12(1):6594-6605. PubMed ID: 34516351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.